Clinical Trials Browser

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Muscle-invasive Bladder Cancer

Lung Neoplasms, Small Cell Lung Carcinoma

Lymphoma, B-Cell

Breast Neoplasms

Colorectal Neoplasms

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung

Urogenital Diseases, Prostatic Diseases

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Breast Neoplasms

Carcinoma, Basal Cell

High-Risk Localized Prostate Cancer

Ras-mutated Metastatic Colorectal Cancer

Advanced Gynecological Malignancies

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

Chemotherapy Induced Anemia

Cancer-Related Anemia

Hemangioma, Capillary

Brain Neoplasms, Meningioma

Advanced Breast Cancer

Solid Tumors

Active Rheumatoid Arthritis

Carcinoma, Non-Small-Cell Lung

Digestive System Neoplasms, Gastrointestinal Stromal Tumors

Resectable Stage II-III Non-small Cell Lung Cancer

Advanced Solid Tumour

Ovarian Neoplasms

Glioblastoma

Glioblastoma

FGFR2 Gene Fusion/Rearrangement

Lymphoma, Follicular

Leukemia, Lymphocytic, Chronic, B-Cell

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Ovarian Epithelial

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Non-small Lung Cancer

Pancreatic Ductal Adenocarcinoma (PDAC)

Lung Neoplasms

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Carcinoma, Non-Small-Cell Lung

Advanced Endometrial Cancer

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

ALANIS

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

preEMBER

A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

ALISCA-Lung2

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer

L19IL2/TNF in Patients With Basal Cell Carcinoma

CHINANEO

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

LM103 in Phase IIa Clinical Trial for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy

Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

SERENA-1b

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer

OPTICAL

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

ReFocus202

TC011_FL_201

MAVRiC

KANNON-5

Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC

Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma

Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib or Sacituzumab Tirumotecan for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

SKB500 Combinations in Patients With Small Cell Lung Cancer

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer

NSCLC

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

A Phase II Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics/Pharmacodynamics of JSKN033 in Patients With Advanced Non-Small Cell Lung Cancer

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer